Fact CheckerSign in

NCT07786324Not yet recruiting

Comparison of Hyperosmolar Agent in Reduction of Increased Intracranial Pressure in Patients With Traumatic Brain Injury Using Ultrasonography

Comparison of 3% Hypertonic Saline Versus 20% Mannitol in Reduction of Increased Intracranial Pressure in Patients With Traumatic Brain Injury Using Optic Nerve Sheath Diameter Measurements''

Source: ClinicalTrials.gov · Last updated 25 Aug 2026

Brief summary (registry, in English)

The aim of this study to compare the efficacy of hypertonic saline and mannitol in reducing intracranial pressure, as assessed by serial optic nerve sheath diameter (ONSD) ultrasound measurements, in patients with traumatic brain injury.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
13 Aug 2026
Start date
1 Oct 2026
Primary completion date
30 Apr 2029
Lead sponsor
Assiut University
NCT number
NCT07786324

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Oct 2026 to the primary completion date, 30 Apr 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • • Penetrating head injury.
    • Hypotension.
    • Previous ocular trauma or orbital surgery.
    • Glaucoma or optic nerve pathology.
    • Bilateral ocular injuries preventing ultrasound assessment.
    • Pregnancy.
    • Chronic renal failure requiring dialysis.
    • Initial serum sodium \>150mmol/L or Patients reaching a sodium level \>160mmol/L during hypertonic administration.
    • Previous hyperosmolar therapy before enrollment.
    • Refusal of consent by legal surrogate.

Who the study is looking for

  • • Age ≥18 years.
    • Acute severe traumatic brain injury (TBI) (GCS 3-8) confirmed by CT brain.
    • Elevated ONSD suggestive of raised ICP (ONSD cutoff value ≥5.6 mm ).(14)
    • Initiation of hyperosmolar therapy within 24 hours of injury.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Assiut University
Coordinator of this site? Confirm its status
AsyutEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.